Polyamine production is downstream and upstream of oncogenic PI3K signalling and contributes to tumour cell growth
Related Experiment Video
Updated: May 15, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
Vinothini Rajeeve1, Wayne Pearce, Marta Cascante
1Analytical Signaling Group, Centre for Cell Signaling, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
Abstract:
PI3K (phosphoinositide 3-kinase) signalling pathways regulate a large array of cell biological functions in normal and cancer cells. In the present study we investigated the involvement of PI3K in modulating small molecule metabolism. A LC (liquid chromatography)-MS screen in colorectal cancer cell lines isogenic for oncogenic PIK3CA mutations revealed an association between PI3K activation and the levels of polyamine pathway metabolites, including 5-methylthioadenosine, putrescine and spermidine. Pharmacological inhibition confirmed that the PI3K pathway controls polyamine production. Despite inducing a decrease in PKB (protein kinase B)/Akt phosphorylation, spermidine promoted cell survival and opposed the anti-proliferative effects of PI3K inhibitors. Conversely, polyamine depletion by an ornithine decarboxylase inhibitor enhanced PKB/Akt phosphorylation, but suppressed cell survival. These results suggest that spermidine mediates cell proliferation and survival downstream of PI3K/Akt and indicate that these two biochemical pathways control each other's activities, highlighting a mechanism by which small molecule metabolism feeds back to regulate kinase signalling. Consistent with this feedback loop having a functional role in these cell models, pharmacological inhibitors of PI3K and ornithine decarboxylase potentiated each other in inhibiting tumour growth in a xenograft model. The results of the present study support the notion that the modulation of spermidine concentrations may be a previously unrecognized mechanism by which PI3K sustains chronic proliferation of cancer cells.
Insights
Phosphoinositide 3-kinase (PI3K) pathway activation influences polyamine metabolism. Spermidine promotes cancer cell survival downstream of PI3K/Akt, revealing a feedback loop that sustains tumor growth.
Area of Science:
- Cell Biology
- Biochemistry
- Cancer Research
Background:
- Phosphoinositide 3-kinase (PI3K) signaling pathways are crucial for numerous cellular functions, including those in cancer.
- The interplay between PI3K signaling and small molecule metabolism in cancer remains an area of active investigation.
Purpose of the Study:
- To investigate the role of PI3K in modulating small molecule metabolism, specifically the polyamine pathway.
- To elucidate the relationship between PI3K/Akt signaling and polyamine metabolites in colorectal cancer.
Main Methods:
- Utilized liquid chromatography-mass spectrometry (LC-MS) to analyze metabolites in colorectal cancer cell lines with PIK3CA mutations.
- Employed pharmacological inhibitors targeting PI3K and ornithine decarboxylase (ODC).
- Assessed tumor growth in a xenograft mouse model.
Main Results:
- PI3K activation was associated with altered levels of polyamine pathway metabolites, including spermidine.
- PI3K inhibition decreased polyamine production, while spermidine enhanced cell survival and counteracted PI3K inhibitor effects.
- Polyamines and PI3K/Akt signaling exhibit reciprocal control, with implications for cancer cell proliferation and survival.
Conclusions:
- Spermidine mediates cell proliferation and survival downstream of PI3K/Akt signaling.
- A feedback loop exists where small molecule metabolism regulates kinase signaling, contributing to chronic cancer cell proliferation.
- Combined inhibition of PI3K and ODC shows synergistic effects on tumor growth, suggesting therapeutic potential.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
IP3/DAG Signaling Pathway
